Skip to main content
BIOTECH logo

BIOTECH — Investor Relations & Filings

Ticker · BST ISIN · ES0184980003 LEI · 959800GNYT6ZZEWPEW29 BME Growth Professional, scientific and technical activities
Open in API
Filings indexed 2,317 across all filing types
Latest filing 2014-08-11 Net Asset Value
Country ES Spain
Listing BME Growth BST

About BIOTECH

https://asebio.com/en/members/directory…

Biotechnology Assets Biat Group is a biotechnology corporate group with a global commercial structure operating through several subsidiaries. Its subsidiary Biobide is a provider of preclinical services, specializing in tailor-made toxicity and efficacy testing using the zebrafish (ZF) animal model. ZIP Solutions develops and promotes a proprietary set of inteins for high-value industrial applications, including gene therapy, immunotherapy, in-vitro diagnostics, smart vaccines (RNA & DNA), and affinity-based protein purification. The Bionatur division manages biotech assets for human and animal health. The group focuses on licensing its platforms and products, conducting preclinical research, and improving recombinant and DNA vaccines through collaborations.

Recent filings

Filing Released Lang Actions
THE BIOTECH GROWTH TRUST PLC - Net Asset Value(s)
Net Asset Value Classification · 1% confidence The document explicitly states 'THE BIOTECH GROWTH TRUST PLC - Net Asset Value(s)' and provides an 'estimated un-audited net asset value' calculated according to AIC guidelines, along with the date (August 8, 2014) and value (527.62p). This content directly matches the definition for Net Asset Value updates, which is classified as NAV.
2014-08-11 English
THE BIOTECH GROWTH TRUST PLC - Transaction in Own Shares
Transaction in Own Shares Classification · 1% confidence The document explicitly states in the title and body that it concerns a 'Transaction in Own Shares' by 'THE BIOTECH GROWTH TRUST PLC'. It details the number of shares purchased, the price, and the resulting total number of shares in issue and voting rights. This directly matches the definition for 'Transaction in Own Shares' (Code: POS). The document length is short (1921 chars), but the content is a direct notification of the transaction itself, not an announcement that a report is attached, thus POS is more specific than RPA or RNS.
2014-08-08 English
THE BIOTECH GROWTH TRUST PLC - Net Asset Value(s)
Net Asset Value Classification · 1% confidence The document explicitly states 'THE BIOTECH GROWTH TRUST PLC - Net Asset Value(s)' and provides a specific figure for the 'estimated un-audited net asset value' as of a certain date (August 7, 2014). This content directly matches the definition for Net Asset Value updates, which is classified as 'NAV'. The document length is short, but the content is the actual NAV figure, not an announcement about the publication of the NAV.
2014-08-08 English
THE BIOTECH GROWTH TRUST PLC - Net Asset Value(s)
Net Asset Value Classification · 1% confidence The document explicitly states 'THE BIOTECH GROWTH TRUST PLC - Net Asset Value(s)' and provides a specific calculated value ('526.31p') as of a certain date ('6 August 2014'). This content directly corresponds to the definition of a Net Asset Value update, which is classified as 'NAV'. The document length is short, but the content is the actual NAV figure, not an announcement about the NAV report.
2014-08-07 English
THE BIOTECH GROWTH TRUST PLC - Interim Management Statement
Interim / Quarterly Report Classification · 1% confidence The document is an 'Interim Management Statement' for The Biotech Growth Trust PLC. It provides substantive financial data, including NAV performance, share price changes, portfolio composition, and investment holdings for the period ending 30 June 2014. While it mentions other events like board changes and AGM results, the core of the document is a comprehensive financial update for an interim period, which fits the definition of an Interim/Quarterly Report (IR). Q1 2014
2014-08-07 English
THE BIOTECH GROWTH TRUST PLC - Net Asset Value(s)
Net Asset Value Classification · 1% confidence The document explicitly states 'THE BIOTECH GROWTH TRUST PLC - Net Asset Value(s)' in the title and provides a specific figure for the 'estimated un-audited net asset value' as of a certain date (August 5, 2014). This directly corresponds to the definition of Net Asset Value (NAV) reporting, which is classified under the code NAV.
2014-08-06 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.